{"SPADE_UN_16484": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16484", "Peptide Name": "BimEL-CTS", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "PQMVILQLLRFIFRLVWRRH", "Sequence Length": 20, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Bcl-2/Bcl-xL", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C125H201N37O23S", "Mass": 2622.23, "PI": 12.0, "Net Charge": 5, "Hydrophobicity": 0.47, "Half Life": "Mammalian:>20 hourYeast:>20 hourE.coli:/", "Literature": [{"Title": "Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2", "Pubmed ID": "30860026", "Reference": "Elife. 2019 Mar 12;8e37689.", "Author": "Liu Q, Osterlund EJ, Chi X, Pogmore J, Leber B, Andrews DW.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30860026"}], "Frequent Amino Acids": "LRF", "Absent Amino Acids": "ACDEGKNOSTUY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 13, "Polar Residues": 9, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_16485", "Similarity": 0.95, "Sequence": "PQMVELQLLRFIFRLVWRRH"}, {"SPADE_ID": "SPADE_UN_16486", "Similarity": 0.95, "Sequence": "PQMVILQLERFIFRLVWRRH"}, {"SPADE_ID": "SPADE_UN_16487", "Similarity": 0.95, "Sequence": "PQMVILQLLRFEFRLVWRRH"}]}}}